NASDAQ:ALGN - Align Technology Stock Price, Price Target & More

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Align Technology, Inc. (NASDAQ:ALGN) posted its quarterly earnings results on Wednesday, April, 25th. The medical equipment provider reported $1.17 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.98 by $0.19. The medical equipment provider earned $436.92 million during the quarter, compared to analyst estimates of $408.27 million. Align Technology had a net margin of 16.12% and a return on equity of 30.36%. The company's revenue was up 40.8% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. View Align Technology's Earnings History.

Align Technology is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Align Technology.

Align Technology issued an update on its second quarter earnings guidance on Wednesday, April, 25th. The company provided EPS guidance of $1.02-1.06 for the period, compared to the Thomson Reuters consensus estimate of $1.03. The company issued revenue guidance of $460-470 million, compared to the consensus revenue estimate of $452.20 million.

15 analysts have issued 12 month price objectives for Align Technology's shares. Their predictions range from $210.00 to $430.00. On average, they expect Align Technology's stock price to reach $330.00 in the next twelve months. This suggests that the stock has a possible downside of 8.9%. View Analyst Ratings for Align Technology.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Align Technology include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Steris (STE), Inogen (INGN), MSA Safety (MSA), Wright Medical Group (WMGI), Halyard Health (HYH), CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN) and RTI Surgical (RTIX).

Media stories about ALGN stock have been trending somewhat negative recently, Accern Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a news sentiment score of -0.06 on Accern's scale. They also gave news articles about the medical equipment provider an impact score of 47.53 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Align Technology's stock is owned by a number of of retail and institutional investors. Top institutional investors include Rathbone Brothers plc (0.27%), Bank of Montreal Can (0.19%), Scout Investments Inc. (0.15%), Fisher Asset Management LLC (0.08%), Gateway Investment Advisers LLC (0.07%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Joseph M Hogan, Julie Tay, Raphael Pascaud, Sreelakshmi Kolli, Stuart A Hockridge, Thomas M Prescott, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.

ALGN stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Rathbone Brothers plc, Fisher Asset Management LLC, Gateway Investment Advisers LLC, DnB Asset Management AS, CenturyLink Investment Management Co, Mckinley Capital Management LLC Delaware and Cim LLC. Company insiders that have sold Align Technology company stock in the last year include C Raymond Larkin Jr, Emory Wright, Greg J Santora, Jennifer Olson, John Morici, Joseph Lacob, Julie Tay, Raphael Pascaud, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.

ALGN stock was purchased by a variety of institutional investors in the last quarter, including Scout Investments Inc., Bank of Montreal Can, Confluence Investment Management LLC, IFM Investors Pty Ltd, Clinton Group Inc., Atria Investments LLC, First Citizens Bank & Trust Co. and State of Alaska Department of Revenue. View Insider Buying and Selling for Align Technology.

Shares of ALGN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALGN stock can currently be purchased for approximately $362.28.

Align Technology has a market capitalization of $29.13 billion and generates $1.47 billion in revenue each year. The medical equipment provider earns $231.41 million in net income (profit) each year or $3.89 on an earnings per share basis. Align Technology employs 8,715 workers across the globe.

Align Technology's mailing address is 2560 ORCHARD PARKWAY, SAN JOSE CA, 95131. The medical equipment provider can be reached via phone at 408-470-1000 or via email at [email protected]